A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects
Clinical trial NCT01894360 · COMPLETED
Trial details
- NCT number
- NCT01894360
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-14
- Primary completion
- 2014-05-13
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.